Immunologic Evaluation of First and Second Doses of <scp>SARS‐CoV‐2 XBB.1.5</scp> and the <scp>KP.2</scp> Monovalent Booster Vaccines in Nursing Home Residents

NHRs who received a two-dose regimen of the XBB.1.5 vaccine demonstrated stronger immune responses and higher pre-KP.2 titers than those who received a single dose. However, the diminished cross-protective neutralization of KP.2 highlights the variant's immune evasiveness. The KP.2 booster effectively elicited anti-KP.2 levels, supporting the continued use of updated, variant-matched boosters to protect high-risk populations such as NHRs.

Authors

Institutions

Publication Details

Journal
Journal of the American Geriatrics Society
Published
2025-12-14
DOI
https://doi.org/10.1111/jgs.70243
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunologic Evaluation of First and Second Doses of SARS‐CoV‐2 XBB.1.5 and the KP.2 Monovalent Booster Vaccines in Nursing Home Residents

Eunice Lim, Lisa Han, Debbie Keresztesy, Christopher L. King et al.
Journal of the American Geriatrics Society
SARS-CoV-2 and COVID-19 Research
article

Immunologic Evaluation of First and Second Doses of SARS‐CoV‐2 XBB.1.5 and the KP.2 Monovalent Booster Vaccines in Nursing Home Residents

Eunice Lim, Lisa Han, Debbie Keresztesy, Christopher L. King, Yasin Abul, Clare Nugent, Irina Suley Tirado Pérez, Stefan Gravenstein, Laurel Holland, Evan Dickerson, Alejandro B. Balazs, Oladayo A. Oyebanji, Brigid Wilson, David H. Canaday, Jürgen Bosch, Ellen See, H. Edward Davidson, Tiffany A. Wallace, Olajide J Olagunju, Chia Jung Li, Mike Payne
article en

Abstract

NHRs who received a two-dose regimen of the XBB.1.5 vaccine demonstrated stronger immune responses and higher pre-KP.2 titers than those who received a single dose. However, the diminished cross-protective neutralization of KP.2 highlights the variant's immune evasiveness. The KP.2 booster effectively elicited anti-KP.2 levels, supporting the continued use of updated, variant-matched boosters to protect high-risk populations such as NHRs.

Journal of the American Geriatrics SocietyVol. 74(3)
Rhode Island Hospital (US), Ragon Institute of MGH, MIT and Harvard (US), Providence VA Medical Center (US), Louis Stokes Cleveland VA Medical Center (US), Center for Global Health (US), Insight Therapeutics (US), Case Western Reserve University (US)
Centers for Disease Control and Prevention
Openalex Percentile: Top 53%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.